Engineers Gate Manager LP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Engineers Gate Manager LP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$439,506
-36.8%
11,569
-49.4%
0.03%
+4.0%
Q2 2022$695,000
-20.6%
22,877
-14.4%
0.02%
-26.5%
Q1 2022$875,000
+32.0%
26,724
+6.4%
0.03%
+13.3%
Q4 2021$663,000
-46.9%
25,128
+190.6%
0.03%
-66.7%
Q1 2020$1,248,000
-6.2%
8,647
-63.6%
0.09%
-15.9%
Q4 2018$1,331,000
-59.4%
23,727
-40.9%
0.11%
-57.5%
Q3 2018$3,280,000
+290.0%
40,114
+66.8%
0.25%
+281.8%
Q2 2018$841,00024,0430.07%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders